Leadership

Ivan A. Valdez, PhD

Founder & Principal, Valdez BioStrategy — a Harvard-trained biomedical scientist and former healthcare strategy consultant.

Ivan A. Valdez, PhD
About the Founder

Founder-led scientific strategy

Founder & Principal, Valdez BioStrategy

Valdez BioStrategy is led by Ivan A. Valdez, PhD, a Harvard-trained biomedical scientist and former healthcare strategy consultant. His work sits at an unusual seam — the mechanistic depth of academic metabolic biology, an understanding of clinical and translational realities, and the strategic judgment of biotech decision-making — helping deep science become a development, evidence, and positioning decision rather than only a paper.

Ivan's perspective has been shaped by training across several leading metabolic-disease research environments, including the Joslin Diabetes Center / Harvard, UT Health San Antonio, and UT Southwestern. Across these settings, he learned from scientific communities whose work helped define modern diabetes biology, insulin resistance, adipose-tissue biology, β-cell dysfunction, and translational metabolic research.

  • PhD, Biological and Biomedical Sciences, Harvard University / Joslin Diabetes Center
  • Postdoctoral training in diabetes and metabolism at UT Health San Antonio
  • Research experience at UT Southwestern
  • Former healthcare strategy consultant at Fletcher Spaght
  • Scientific focus: islet biology, beta-cell function, incretin biology, type 2 diabetes, obesity, translational metabolism
Scientific Focus

Depth where it matters

The practice is grounded in diabetes, obesity, and metabolic disease — incretin biology, islet biology and beta-cell function, glucagon biology, and translational metabolism — and brings mechanistic depth together with the strategic judgment to turn it into clear direction.

Engagements are founder-led: Ivan leads each engagement directly, drawing on the advisory bench only when a scoped question calls for complementary expertise.

Have a scientific strategy question?

For confidential biotech, spinout, investor, or strategic diligence inquiries, start with a brief scoping conversation.

Request a confidential scoping call

Prefer email? contact@valdezbiostrategy.com